Menu
Back to Journals » Vascular Health and Risk Management » Volume 13 » default
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1489)
- Volume 19, 2023 (79)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 13, 2017
Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants
ten Cate H, Henskens YMC, Lancé MD
Vascular Health and Risk Management 2017, 13:457-467
Published Date: 13 December 2017
Extracorporeal ultrafiltration for acute heart failure: patient selection and perspectives
Milazzo V, Cosentino N, Marenzi G
Vascular Health and Risk Management 2017, 13:449-456
Published Date: 11 December 2017
Pelvic vein incompetence: clinical perspectives
Riding DM, Hansrani V, McCollum C
Vascular Health and Risk Management 2017, 13:439-447
Published Date: 27 November 2017
Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease
Mordi IR, Badar AA, Irving RJ, Weir-McCall JR, Houston JG, Lang CC
Vascular Health and Risk Management 2017, 13:427-437
Published Date: 21 November 2017
Endothelial dysfunction assessment by flow-mediated dilation in a high-altitude population
Calderón-Gerstein WS, López-Peña A, Macha-Ramírez R, Bruno-Huamán A, Espejo-Ramos R, Vílchez-Bravo S, Ramírez-Breña M, Damián-Mucha M, Matos-Mucha A
Vascular Health and Risk Management 2017, 13:421-426
Published Date: 21 November 2017
Treatment of pulmonary hypertension with left heart disease: a concise review
Desai A, Desouza SA
Vascular Health and Risk Management 2017, 13:415-420
Published Date: 6 November 2017
Quick reference guide to apixaban [Corrigendum]
Hurst KV, O'Callaghan JM, Handa A
Vascular Health and Risk Management 2017, 13:413-414
Published Date: 26 October 2017
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
Yugar-Toledo JC, Modolo R, de Faria AP, Moreno H
Vascular Health and Risk Management 2017, 13:403-411
Published Date: 16 October 2017
Implementing clinical process management of vascular wounds in a tertiary facility: impact evaluation of a performance improvement project
Avruscio G, Tocco-Tussardi I, Bordignon G, Vindigni V
Vascular Health and Risk Management 2017, 13:393-401
Published Date: 16 October 2017
Factors associated with high brachial–ankle pulse wave velocity in non-hypertensive and appropriately treated hypertensive patients with atherosclerotic risk factors
Ato D, Sawayama T
Vascular Health and Risk Management 2017, 13:383-392
Published Date: 10 October 2017
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
Yandrapalli S, Andries G, Biswas M, Khera S
Vascular Health and Risk Management 2017, 13:369-382
Published Date: 5 October 2017
Evaluation of vitamin D levels in relation to coronary CT angiographic findings in an Iranian population
Moradi M, Foroutanfar A
Vascular Health and Risk Management 2017, 13:361-367
Published Date: 4 October 2017
Right ventricular systolic function in hypertensive heart failure
Oketona OA, Balogun MO, Akintomide AO, Ajayi OE, Adebayo RA, Mene-Afejuku TO, Oketona OT, Bamikole OJ
Vascular Health and Risk Management 2017, 13:353-360
Published Date: 27 September 2017
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
Catapano AL, Pirillo A, Norata GD
Vascular Health and Risk Management 2017, 13:343-351
Published Date: 4 September 2017
Evaluation of bleeding in patients receiving direct oral anticoagulants
Hellenbart EL, Faulkenberg KD, Finks SW
Vascular Health and Risk Management 2017, 13:325-342
Published Date: 23 August 2017
Endothelial dysfunction in patients with Buerger disease
Igari K, Kudo T, Toyofuku T, Inoue Y
Vascular Health and Risk Management 2017, 13:317-323
Published Date: 23 August 2017
Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure
Ojji DB, Lecour S, Adeyemi OM, Sliwa K
Vascular Health and Risk Management 2017, 13:311-316
Published Date: 16 August 2017
Evaluation of pain during endovenous laser ablation of the great saphenous vein with ultrasound-guided femoral nerve block
Al Wahbi AM
Vascular Health and Risk Management 2017, 13:305-309
Published Date: 10 August 2017
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
Aghel N, Delgado DH, Lipton JH
Vascular Health and Risk Management 2017, 13:293-303
Published Date: 4 August 2017
Reversal of direct oral anticoagulants
Almegren M
Vascular Health and Risk Management 2017, 13:287-292
Published Date: 19 July 2017
Hypertension and blood pressure variability management practices among physicians in Singapore
Setia S, Subramaniam K, Tay JC, Teo BW
Vascular Health and Risk Management 2017, 13:275-285
Published Date: 17 July 2017
Use of angiotensin-converting enzyme inhibitors and freedom from amputation after lower extremity revascularization
Kray JE, Dombrovskiy VY, Vogel TR
Vascular Health and Risk Management 2017, 13:269-274
Published Date: 14 July 2017
Quick reference guide to apixaban
Hurst KV, O'Callaghan JM, Handa A
Vascular Health and Risk Management 2017, 13:263-267
Published Date: 10 July 2017
Focusing on a complete blood cell parameter: mean platelet volume levels may be a predictor of coronary slow flow
Yılmaz M, Dağlı MN, Uku Ö, Bilen MN, Korkmaz H, Erdem K, Kurtoğlu E
Vascular Health and Risk Management 2017, 13:255-261
Published Date: 7 July 2017
Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy
Jetty V, Glueck CJ, Lee K, Goldenberg N, Prince M, Kumar A, Goldenberg M, Anand I, Wang P
Vascular Health and Risk Management 2017, 13:247-253
Published Date: 6 July 2017
Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study
Ermini G, Perrone V, Veronesi C, Degli Esposti L, Di Pasquale G
Vascular Health and Risk Management 2017, 13:239-246
Published Date: 5 July 2017
Annual deterioration of renal function in hypertensive patients with and without diabetes
Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S
Vascular Health and Risk Management 2017, 13:231-237
Published Date: 26 June 2017
Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism
Mesquita PN, Dornelas Leão Leite AP, Chagas Crisostomo S, Veras Filho E, Cunha Xavier L, Bandeira F
Vascular Health and Risk Management 2017, 13:225-229
Published Date: 22 June 2017
Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery
Krog AH, Sahba M, Pettersen EM, Wisloff T, Sundhagen JO, Kazmi SSH
Vascular Health and Risk Management 2017, 13:217-224
Published Date: 19 June 2017
Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial [Erratum]
Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS
Vascular Health and Risk Management 2017, 13:215-216
Published Date: 19 June 2017
Worksite-based cardiovascular risk screening and management: a feasibility study
Padwal R, Rashead M, Snider J, Morrin L, Lehman A, Campbell NRC
Vascular Health and Risk Management 2017, 13:209-213
Published Date: 12 June 2017
Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation method
Fernández-Cidón B, Padró-Miquel A, Alía-Ramos P, Castro-Castro MJ, Fanlo-Maresma M, Dot-Bach D, Valero-Politi J, Pintó-Sala X, Candás-Estébanez B
Vascular Health and Risk Management 2017, 13:201-207
Published Date: 6 June 2017
Totally laparoscopic aortobifemoral bypass surgery in the treatment of aortoiliac occlusive disease or abdominal aortic aneurysms – a systematic review and critical appraisal of literature
Helgetveit I, Krog AH
Vascular Health and Risk Management 2017, 13:187-199
Published Date: 18 May 2017
Pediatric ventricular assist devices: current challenges and future prospects
Burki S, Adachi I
Vascular Health and Risk Management 2017, 13:177-185
Published Date: 15 May 2017
Patient-perceived health-related quality of life before and after laparoscopic aortobifemoral bypass
Kazmi SSH, Krog AH, Berge ST, Sundhagen JO, Sahba M, Falk RS
Vascular Health and Risk Management 2017, 13:169-176
Published Date: 12 May 2017
Infrainguinal open reconstruction: a review of surgical considerations and expected outcomes
Komshian SR, Lu K, Pike SL, Siracuse JJ
Vascular Health and Risk Management 2017, 13:161-168
Published Date: 8 May 2017
Pulmonary hypertension in Nigerian adults with sickle cell anemia
Amadi VN, Balogun MO, Akinola NO, Adebayo RA, Akintomide AO
Vascular Health and Risk Management 2017, 13:153-160
Published Date: 8 May 2017
The changing trend of cardiovascular disease and its clinical characteristics in Ethiopia: hospital‑based observational study
Tefera YG, Abegaz TM, Abebe TB, Mekuria AB
Vascular Health and Risk Management 2017, 13:143-151
Published Date: 21 April 2017
Impact of around-the-clock in-house cardiology fellow coverage on door-to-balloon time in an academic medical center
Kohan LC, Nagarajan V, Millard MA, Loguidice MJ, Fauber NM, Keeley EC
Vascular Health and Risk Management 2017, 13:139-142
Published Date: 18 April 2017
High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
Goss F, Brachmann J, Hamm CW, Haerer W, Reifart N, Levenson B
Vascular Health and Risk Management 2017, 13:127-137
Published Date: 6 April 2017
DPP-4 inhibitor treatment: β-cell response but not HbA1c reduction is dependent on the duration of diabetes
Kozlovski P, Bhosekar V, Foley JE
Vascular Health and Risk Management 2017, 13:123-126
Published Date: 31 March 2017
New pharmacological and technological management strategies in heart failure
Chaudhry SP, Stewart GC
Vascular Health and Risk Management 2017, 13:111-121
Published Date: 21 March 2017
Early discharge compared with ordinary discharge after percutaneous coronary intervention – a systematic review and meta-analysis of safety and cost
Abdelnoor M, Andersen JG, Arnesen H, Johansen O
Vascular Health and Risk Management 2017, 13:101-109
Published Date: 20 March 2017
Aerobic fitness is associated with low cardiovascular disease risk: the impact of lifestyle on early risk factors for atherosclerosis in young healthy Swedish individuals – the Lifestyle, Biomarker, and Atherosclerosis study
Fernström M, Fernberg U, Eliason G, Hurtig-Wennlöf A
Vascular Health and Risk Management 2017, 13:91-99
Published Date: 15 March 2017
Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
Alipour A, Wintgens LIS, Swaans MJ, Balt JC, Rensing BJWM, Boersma LVA
Vascular Health and Risk Management 2017, 13:81-90
Published Date: 6 March 2017
Prognostic indices among hypertensive heart failure patients in Nigeria: the roles of 24-hour Holter electrocardiography and 6-minute walk test
Mene-Afejuku TO, Balogun MO, Akintomide AO, Adebayo RA
Vascular Health and Risk Management 2017, 13:71-79
Published Date: 27 February 2017
Questionable accuracy of home blood pressure measurements in the obese population – Validation of the Microlife WatchBP O3® and Omron RS6® devices according to the European Society of Hypertension-International Protocol
Azaki A, Diab R, Harb A, Asmar R, Chahine MN
Vascular Health and Risk Management 2017, 13:61-69
Published Date: 27 February 2017
Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation
Salzwedel A, Heidler MD, Haubold K, Schikora M, Reibis R, Wegscheider K, Jöbges M, Völler H
Vascular Health and Risk Management 2017, 13:55-60
Published Date: 23 February 2017
An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes
Messana JA, Schwartz SS, Townsend RR
Vascular Health and Risk Management 2017, 13:43-54
Published Date: 17 February 2017
Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
Tarantino N, Santoro F, De Gennaro L, Correale M, Guastafierro F, Gaglione A, Di Biase M, Brunetti ND
Vascular Health and Risk Management 2017, 13:29-41
Published Date: 16 February 2017
An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia
Bove M, Cicero AFG, Veronesi M, Borghi C
Vascular Health and Risk Management 2017, 13:23-28
Published Date: 8 February 2017
Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006–2012
An R, Wang PP
Vascular Health and Risk Management 2017, 13:15-21
Published Date: 20 January 2017
Complex neurological symptoms in bilateral thalamic stroke due to Percheron artery occlusion
Caruso P, Manganotti P, Moretti R
Vascular Health and Risk Management 2017, 13:11-14
Published Date: 22 December 2016
Inverse relationship of cardioankle vascular index with BMI in healthy Japanese subjects: a cross-sectional study
Nagayama D, Imamura H, Sato Y, Yamaguchi T, Ban N, Kawana H, Ohira M, Saiki A, Shirai K, Tatsuno I
Vascular Health and Risk Management 2017, 13:1-9
Published Date: 21 December 2016